Gastrointestinal Cancer | Specialty

The OncLive Gastrointestinal Cancer condition center page is a comprehensive resource for clinical news and expert insights on various types of gastrointestinal (GI) cancers, including hepatocellular carcinoma, gastric cancer, pancreatic cancer, colorectal cancer, cholangiocarcinoma, esophageal cancer, and more. This page features news articles, interviews in written and video format, and podcasts that focus on unmet needs, treatment advances, and ongoing research in GI cancers.

FDA Green-Lights Phase III Trial for Drug-Eluting Microspheres in Liver Cancer

March 9th 2011

The FDA has given Merit Medical Systems the green light for a phase III clinical trial investigating QuadraSphere Microspheres in patients with primary liver cancer.

FDA Considers Approval of Fusilev for Colorectal Cancer

March 9th 2011

The FDA has notified Spectrum Pharmaceuticals that it will decide whether to approve Fusilev (levoleucovorin) for colorectal cancer within 6 months.

Net Guides: Colon Cancer

March 8th 2011

Useful Online Resources and Clinical Trials for Colon Cancer

Net Guides: Liver Cancer

March 7th 2011

Useful Online Resources and Clinical Trials for Liver Cancer

Net Guides: Gastrointestinal Cancers

March 6th 2011

Useful Online Resources and Clinical Trials for Gastrointestinal Cancers

2011 Gastrointestinal Cancers Symposium

March 6th 2011

ColoPrint, a microarray-based gene signature test, accurately identifi ed the risk of recurrence of colorectal cancer in patients with localized stage II disease, raising the potential of an exciting new prognostic tool for clinicians.

John Theurer Cancer Center Opens New Comprehensive Facility

March 4th 2011

The John Theurer Cancer Center (JTCC) at Hackensack University Medical Center in New Jersey, one of the largest cancer centers in the United States

Interview With Siddhartha Mukherjee, Author of The Emperor of All Maladies

March 4th 2011

Siddhartha Mukherjee, MD, discusses his book The Emperor of All Maladies.

Avastin Alarm

March 4th 2011

A meta-analysis of randomized controlled trials revealed treatment-related fatalities were 1.5 times higher for combination treatment with Avastin (bevacizumab) and chemotherapy versus chemotherapy alone

Afinitor Active in Pancreatic NET

March 4th 2011

In the RADIANT-3 (RAD001 In Advanced Neuroendocrine Tumors) phase III study involving patients with pancreatic neuroendocrine tumors (NET)

Canine Cancer Hounds

March 4th 2011

A black Labrador retriever was able to detect colorectal cancer >90% of the time when sniffing a patient%u2019s breath or stool sample.

Racial/Ethnic and Age Disparities in Chemotherapy Selection for Colorectal Cancer

March 3rd 2011

Studies have evaluated racial/ethnic and age disparities in whether patients receive chemotherapy for nonmetastatic colo-rectal cancer

ASCO GI Coverage: Women Who Use Bisphosphonates for Osteoporosis Reduce Their Risk of Colorectal Cancer

March 2nd 2011

The risk of colorectal cancer declined by 33% among postmenopausal women taking oral bisphosphonates for osteoporosis

ASCO GI Coverage: Australian Study Finds ISH to Be the Best Assessor of HER2 Expression in Gastric Cancer

March 2nd 2011

In situ hybridization (ISH) yields the best results for assessing HER2 expression in gastric cancer, according to a multilaboratory analysis of testing methods.

ASCO GI Coverage: Study Finds Tumor Characteristics Correlate With Survival in Stomach, Esophageal Cancers

March 2nd 2011

An analysis of the National Cancer Institute's Surveillance Epidemiology and End Results (SEER) database showed that advanced gastric or esophageal cancer confers a poor prognosis

ASCO GI Coverage: Imatinib Trough Levels Remain Stable in Most Advanced GIST Patients During Long-Term Treatment

March 2nd 2011

Patients with gastrointestinal stromal tumors (GIST) had stable plasma concentrations of imatinib during long-term treatment, reported Yoon-Koo Kang, MD, PhD, and colleagues at the Gastrointestinal Cancers Symposium.

ASCO GI Coverage: European Study Shows Bevacizumab to Be Ineffective as Adjuvant Therapy

March 2nd 2011

The results of a large, multicenter trial showed that the addition of bevacizumab to adjuvant chemotherapy failed to improve disease-free survival (DFS) compared with chemotherapy alone.

ASCO GI Interview Series: Robert Rosenberg, MD, Discusses Advantages of ColoPrint Test

March 2nd 2011

At the 2011 symposium in San Francisco, California, Oncology & Biotech News spoke with the author of one of the featured presentations at the meeting

ASCO GI Interview Series: Improving Patient Outcomes in Pancreatic Cancer: A Conversation with Mitchell C. Posner, MD

March 2nd 2011

Few cancers have a bleaker outlook than pancreatic cancer.

Oncology Community Facing Severe Drug Shortages

December 19th 2010

Hospitals, pharmacists, and physicians across the United States are reporting shortages of critical anticancer drugs, including carboplatin, cisplatin, dacarbazine, fludarabine, and cytarabine.